Statistics on Biotechnology Use Results by fields of operation Business Sector Biotechnology indicators by branch of activity. Unidades: specified in variables Total Companies Services Industry and Construction Agriculture No. of companies carrying out R&D in Biotechnology 1.299 774 424 101 %Companies according to biotechnology used: Genetic code 30,8 39,6 16,8 22,4 %Companies according to biotechnology used: Functional units 38,4 42,6 34,2 23,7 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 21,5 26 14,3 17,4 %Companies according to biotechnology used: Bioprocesses 50,8 40 74,7 32,7 %Companies according to biotechnology used: Sub-cellular organisms 8,5 11,6 4,3 2,1 %Companies according to biotechnology used: Bio-computing 24 34,5 9,1 6 %Companies according to biotechnology used: Nanobiotechnology 12,1 16,8 6,1 1 %Companies according to biotechnology used: Other 16,9 19 8,1 37,6 Companies in which biotechnology activities are: Main and/or exclusive 559 442 97 21 Companies in which biotechnology activities are: A secondary line of business 230 129 83 18 Companies in which biotechnology activities are: A tool necessary for production 510 203 244 63 %Company by field(s) of ultimate application of biotechnology use: Human Health 45,5 61,2 26,2 6,2 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 15,5 16,9 11 23,7 %Company by field(s) of ultimate application of biotechnology use: Food products 32,3 21,7 51,5 32,9 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 23,8 20,4 21,3 59,8 %Company by field(s) of ultimate application of biotechnology use: Environment 15,6 16,3 14,9 13,4 %Company by field(s) of ultimate application of biotechnology use: Industry 13,7 14,6 14,5 4,1 Personnel in R&D in biotechnology (no. of persons) 15.750 9.680 5.035 1.036 Personnel in R&D in biotechnology (no. of persons): Research personnel 8.379 5.975 2.144 261 Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel 7.371 3.704 2.891 775 Personnel in R&D in biotechnology (no. of persons). Women 8.711 5.499 2.773 438 Personnel in R&D in biotechnology (no. of persons). Women: Research personnel 4.510 3.287 1.119 104 Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel 4.200 2.212 1.655 333 Personnel in R&D in biotechnology (FTE) 11.528,6 7.260,7 3.657,9 610,1 Personnel in R&D in biotechnology (FTE): Research personnel 6.342,7 4.531,8 1.631,6 179,3 Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel 5.185,9 2.728,8 2.026,3 430,8 Personnel in R&D in biotechnology (FTE). Women 6.539,7 4.129,4 2.140,4 270 Personnel in R&D in biotechnology (FTE). Women: Research personnel 3.455,7 2.476,3 905,7 73,7 Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel 3.084 1.653 1.234,7 196,3 Internal expenditure on R&D (thousands of euros) 1.038.582 614.188 382.984 41.410 1) By nature of the expense: Current expenses 940.091 558.041 344.917 37.132 1.1) Remuneration to research personnel 321.570 213.833 98.160 9.577 1.2) Remuneration to technicians and auxiliary personnel 194.836 94.194 87.790 12.851 1.3) Other current expenses 423.685 250.013 158.967 14.704 2) By nature of the expense: Capital expenses 98.492 56.147 38.067 4.278 2.1) Land and buildings 10.199 6.083 2.952 1.165 2.2) Equipment and instruments 72.584 38.296 32.431 1.858 2.3) Acquisition of specific R&D software 5.721 3.732 1.850 138 2.4) Otros productos de propiedad intelectual específicos para I+D 9.987 8.037 833 1.117 1.1) By origin of the funds: Own funds 711.488 359.197 316.843 35.448 1.2) By origin of the funds: From companies 121.738 107.930 9.208 4.600 1.3) By origin of the funds: Public Administration funds 107.477 91.272 14.871 1.334 1.4) By origin of the funds: From Universities 192 182 11 0 1.5) By origin of the funds: From non profit private institutions 10.756 10.585 171 0 1.6) By origin of the funds: Foreign funds 86.931 45.023 41.880 27 Purchase of R&D services in biotechnology (thousands of euros) 145.557 74.421 70.048 1.088 Purchase of R&D services in biotechnology (thousands of euros): In Spain 95.915 52.406 42.780 729 Purchase of R&D services in biotechnology (thousands of euros): Abroad 49.642 22.015 27.268 359 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 40,2 48,8 28 25,5 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 13,2 13 14,2 10,2 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 19 20,3 17,3 16,3 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 11,5 11,5 11,4 12,1 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 15,9 18 12,5 13,4 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 17 20,3 11,3 15,3 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 16,4 16,5 16,5 16,1 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 40,5 42,9 37,1 36,7 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 55 58,7 48,7 52,9 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 21,9 22,3 20,1 26,3 % Companies with income of an international origin related to biotechnological activities 23,5 26,2 22,4 7,2 % Turnover representing income of an international origin related to biotechnological activities 1,9 4,1 1,6 2,2 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 61,6 62,4 61,2 68,3 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 38,4 37,6 38,8 31,7 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 87,6 83,2 89,1 85 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 10,9 12,2 10,8 0 % Income of an international origin related with activities according to the classification: Operating source abroad 1,1 4,3 0,1 0 % Income of an international origin related with activities according to the classification: Other 0,4 0,3 0 15 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute